Act Capital Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Eiger Bio Pharmaceuticals, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 235,000 shares of EIGR stock, worth $2.97 Million. This represents 2.44% of its overall portfolio holdings.
Number of Shares
235,000
Previous 250,000
6.0%
Holding current value
$2.97 Million
Previous $1.58 Million
12.38%
% of portfolio
2.44%
Previous 2.2%
Shares
3 transactions
Others Institutions Holding EIGR
# of Institutions
6Shares Held
748KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY345KShares$4.36 Million0.64% of portfolio
-
Drw Securities, L.L.C. Chicago, IL120KShares$1.52 Million0.02% of portfolio
-
Dfpg Investments, LLC32.4KShares$410,2390.0% of portfolio
-
Zeke Capital Advisors, LLC Berwyn, PA13KShares$164,4500.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.25KShares$28,4620.0% of portfolio
About Eiger BioPharmaceuticals, Inc.
- Ticker EIGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,966,800
- Market Cap $556M
- Description
- Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...